Literature DB >> 439106

An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.

M Webley, E N Coomes.   

Abstract

One hundred and fourteen patients with rheumatoid arthritis who had received treatment with penicillamine are reviewed. Side effects occurred in 50 patients. Sixty patients were considered to be improved with the drug. Low and high maintenance regimes were compared. There was no significant difference in the incidence of side effects or clinical improvement. Previous gold therapy did not influence the therapeutic response or total incidence of side effects observed with penicillamine. Rashes were, however, more common if patients had previously had treatment with gold.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 439106

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

Review 2.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

3.  Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

Authors:  R D Situnayake; K A Grindulis; B McConkey
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

4.  Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis.

Authors:  M W Bentzon; I Gad; P Halberg; O Halskov; B K Jacobsen; I Lorenzen; N Morling; A Svejgaard
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.